<DOC>
	<DOCNO>NCT02117414</DOCNO>
	<brief_summary>The purpose Evera MRI™ study confirm safety efficacy Evera MRI ICD ( Implantable cardioverter-defibrillator ) System clinical MRI ( Magnetic Resonance Imaging ) environment subject receive MRI scan without position restriction ( MRI scan may occur anywhere body ) .</brief_summary>
	<brief_title>Confirmatory Clinical Trial Evera MRI System Conditionally-safe MRI Access</brief_title>
	<detailed_description />
	<criteria>Subjects indicate implantation ICD time study enrollment . Subjects able undergo pectoral implant . Subjects receive ICD first time . Subjects able willing undergo elective MRI scan without sedation . Subjects geographically stable available followup study site length study . Subjects least 18 year age ( old , require local law ) . Subjects history significant tricuspid valvular disease . Subjects single dose 1.0mg dexamethasone sodium phosphate and/or dexamethasone acetate may contraindicate . Subjects require legally authorize representative obtain informed consent . Subjects undergoing device upgrade , changeouts , lead extraction , and/or lead device revision . Subjects abandon capped lead . Subjects require indicated MRI scan , specifically describe Evera MRI™ study , onemonth postMRI/waiting period followup ( approximately 4 month postimplant ) . Subjects nonMRI compatible device ( neurostimulators ) material implant ( e.g. , nonMRI compatible sternal wire , neurostimulators , biostimulators , metal alloy ) . Subjects medical condition preclude test require study protocol limit study participation . Subjects enrol intend participate another clinical trial ( investigational drug device , new indication approve drug device , requirement additional test beyond standard clinical practice ) Evera MRI™ study . Coenrollment concurrent trial allow documented preapproval obtain Medtronic study manager . Female patient pregnant , childbearing potential reliable form birth control . Women childbearing potential require negative pregnancy test within seven ( 7 ) day prior device implant . Subjects exclusion criterion require local law ( e.g. , age , breastfeed ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Magnetic Resonance Imaging ( MRI )</keyword>
</DOC>